8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Nov 2, 2006)

Filed November 2, 2006For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on November 2, 2006, to report its financial results for the quarter and nine months ended September 30, 2006. This filing primarily serves to furnish the press release detailing these results, which is attached as Exhibit 99.1. Investors should note that while this report announces the company's financial performance, the information within is furnished and not considered "filed" for the purposes of Section 18 of the Exchange Act. This means it's primarily for disclosure and doesn't carry the same legal implications as a formally filed document. For detailed financial figures and operational commentary, investors need to refer to the press release itself (Exhibit 99.1).

Key Highlights

  • 1Alnylam Pharmaceuticals announced its financial results for the third quarter and the first nine months of 2006 on November 2, 2006.
  • 2The full details of the financial results are provided in a press release, furnished as Exhibit 99.1 to the 8-K.
  • 3The report confirms the date of the earliest event reported as November 2, 2006.
  • 4The filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
  • 5The information furnished in this 8-K, including the press release, is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
  • 6The principal executive offices are located in Cambridge, MA.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce and provide Alnylam Pharmaceuticals' financial results for the quarter and the nine-month period ended September 30, 2006, through an accompanying press release.

The detailed financial results are contained within the press release dated November 2, 2006, which is furnished as Exhibit 99.1 to this 8-K filing.

No, the information in this 8-K filing, including the press release, is furnished and not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. Therefore, it does not carry the same legal liabilities as formally filed documents.

The report was signed by John M. Maraganore, President and Chief Executive Officer, on November 2, 2006.